DAM Capital Advisors IPO subscribed 4.44 times on Day 3. Check GMP and other details
Team Finance Saathi
20/Dec/2024

What's covered under the Article:
- DAM Capital Advisors IPO opens December 19-23, 2024, showing a 4.44 times subscription.
- IPO GMP shows potential listing gains of 28.27%.
- How to check allotment status and the valuation of the company.
DAM Capital Advisors IPO: Overview and Details
DAM Capital Advisors, one of the fastest-growing investment banks in India, is offering an IPO amounting to ₹840.25 Crores. This Offer for Sale consists entirely of 2.97 Crores shares. The subscription period for the DAM Capital Advisors IPO runs from December 19 to December 23, 2024, with the allotment date scheduled for December 24, 2024. The shares will be listed on the BSE and NSE, with a tentative listing date of December 27, 2024.
IPO Pricing and Investment Details
The price band for the IPO is ₹269 to ₹283 per share, with a market capitalization of ₹2,000.41 Crores at the upper price band. The lot size is 53 shares, and retail investors need to invest a minimum of ₹14,999, while HNIs must invest for a minimum of 742 shares, amounting to ₹2,09,986.
The book-running lead manager for the issue is Nuvama Wealth Management Limited, while Link Intime India Private Limited is the registrar.
DAM Capital Advisors IPO Grey Market Premium (GMP)
The Grey Market Premium (GMP) for the DAM Capital Advisors IPO indicates a potential listing gain of ₹80 (or 28.27%). This shows strong investor demand, but it’s important to note that GMP is not a guaranteed indicator of the listing price. Here's the GMP trend for the IPO:
- 18 December 2024: ₹80 (28.27% increase in expected listing price)
Live Subscription Status
As of 12:30 PM on December 20, 2024, the DAM Capital Advisors IPO has been subscribed 4.44 times on its second day of subscription, reflecting strong demand. You can check the live subscription status on the BSE website for real-time updates.
Anchor Investors and Fundraising
DAM Capital Advisors has raised ₹251.48 Crores from Anchor Investors at ₹283 per share. The company has allocated 88,86,268 equity shares to the Anchor Investors, which reflects solid institutional interest in the IPO.
IPO Allotment Status Guide
The allotment date for the DAM Capital Advisors IPO is December 24, 2024, and investors can check their allotment status via the registrar’s website. Here’s how to check:
- Visit the IPO allotment status page on the registrar’s website.
- Select DAM Capital Advisors Limited IPO from the dropdown list.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to view your allotment status.
Objectives of DAM Capital Advisors Limited IPO
DAM Capital Advisors will not receive any proceeds from the Offer for Sale; the selling shareholders will retain the proceeds after deducting related expenses and taxes.
DAM Capital Advisors IPO Review
DAM Capital Advisors is a prominent investment bank with a strong track record, boasting the highest profit margin in Fiscal 2024 among its peers. The company is among the leading investment banks in India with a 12.1% market share based on the number of initial public offerings (IPOs) and qualified institutional placements (QIPs) managed in Fiscal 2024.
Financial Overview
The company has shown significant growth, with revenues for FY24 reaching ₹1,800.42 Million, and Profit after Tax (PAT) for FY24 amounting to ₹705.23 Million. The pre-issue P/E ratio is 28.36x, and the post-issue P/E ratio stands at 28.37x, which is slightly above the industry average of 24x, indicating that the IPO is fairly priced. The company's ROCE for FY24 is 72.7%, and ROE stands at 58.72%, showcasing its strong financial performance and high return potential.
Given the strong financial metrics and 28.27% GMP, we recommend risky investors to consider applying for the DAM Capital Advisors IPO for listing gains.
Investment Opportunity
For those looking to invest in one of India’s top investment banks, the DAM Capital Advisors IPO offers a great opportunity. With strong financials, high demand, and solid GMP trends, this IPO is an appealing option for those seeking listing gains.